Shareholders Equity: The sum of preferred and common equity items.
Impact Biomedical Inc. (IBO) had Shareholders Equity of $15.55M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.01M |
|
$5.25M |
|
$0.41M |
|
$-0.41M |
|
$1.18M |
|
$-1.17M |
|
$3.83M |
|
$2.65M |
|
$2.65M |
|
$5.24M |
|
$5.24M |
|
$5.24M |
|
$5.24M |
|
$-1.17M |
|
$-0.89M |
|
31.55M |
|
31.55M |
|
$1.03 |
|
$1.03 |
|
| Balance Sheet Financials | |
$0.41M |
|
-- |
|
$16.99M |
|
$17.41M |
|
$1.16M |
|
-- |
|
$0.69M |
|
$1.85M |
|
$15.55M |
|
$-1.44M |
|
|
Shareholders Equity |
$15.55M |
104.62M |
|
| Cash Flow Statement Financials | |
$-1.89M |
|
$0.00M |
|
$-0.11M |
|
$2.00M |
|
$0.00M |
|
$-2.00M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5785.71% |
|
-16728.57% |
|
-16728.57% |
|
-- |
|
37928.57% |
|
74928.55% |
|
$-1.89M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
6.54 |
|
1.40 |
|
64.29 |
|
33.65% |
|
-363.79% |
|
30.08% |
|
33.65% |
|
$0.15 |
|
$-0.06 |
|
$-0.06 |
|